(Q41065404)

26 September 2017

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease (English)

1 reference

26 September 2017

0 references

Jennifer M Knight-Madden

8

object named as

Jennifer Knight-Madden

1 reference

26 September 2017

10

Victor R Gordeuk

1 reference

26 September 2017

Kenneth I Ataga

1

1 reference

26 September 2017

Abdullah Kutlar

2

1 reference

26 September 2017

Julie Kanter

3

1 reference

26 September 2017

Darla Liles

4

1 reference

26 September 2017

Rodolfo Cancado

5

1 reference

26 September 2017

João Friedrisch

6

1 reference

26 September 2017

Troy H Guthrie

7

1 reference

26 September 2017

Ofelia A Alvarez

9

1 reference

26 September 2017

Sandra Gualandro

11

1 reference

26 September 2017

Marina P Colella

12

1 reference

26 September 2017

Wally R Smith

13

1 reference

26 September 2017

Scott A Rollins

14

1 reference

26 September 2017

Jonathan W Stocker

15

1 reference

26 September 2017

Russell P Rother

16

1 reference

26 September 2017

language of work or name

English

0 references

publication date

3 December 2016

1 reference

The New England Journal of Medicine

26 September 2017

1 reference

26 September 2017

376

1 reference

26 September 2017

5

1 reference

26 September 2017

429-439

1 reference

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Sickle cell pain: a critical reappraisal

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell disease

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Platelet-neutrophil-interactions: linking hemostasis and inflammation

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

P-selectin mediates the adhesion of sickle erythrocytes to the endothelium

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker se

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Pathogenesis and treatment of sickle cell disease

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5481200

Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27959701

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27959701

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27959701

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1611770

1 reference

26 September 2017

1 reference

26 September 2017

PubMed publication ID

27959701

1 reference